Abstract
In industrialized countries, age-related macular degeneration (AMD) is the leading cause of blindness in elderly people. Hallmarks of the non-neovascular (dry) form of AMD are the formation of drusen and geographic atrophy, whereas the exudative (wet) form of the disease is characterized by invading blood vessels. In retinal angiomatous proliferation (RAP), a special form of wet AMD, intraretinal vessels grow from the deep plexus into the subretinal space. Little is known about the mechanisms leading to intraretinal neovascularization, but age-related changes such as reduction of choroidal blood flow, accumulation of drusen, and thickening of the Bruch’s membrane may lead to reduced oxygen availability in photoreceptors. Such a chronic hypoxic situation may induce several cellular response pathways including the stabilization of hypoxia-inducible factors (HIFs) and the production of angiogenic factors, such as vascular endothelial growth factor (VEGF). Here, we discuss the potential contribution of hypoxia and HIFs in RAP disease pathology and in some mouse models for subretinal neovascularization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AMD:
-
Age-related macular degeneration
- CNV:
-
Choroidal neovascularization
- HIF:
-
Hypoxia-inducible factors
- PND:
-
Postnatal day
- RAP:
-
Retinal angiomatous proliferation
- RPE:
-
Retinal pigment epithelium
- VEGF:
-
Vascular endothelial growth factor
- VLDLR:
-
Very low-density lipoprotein receptor
References
Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487
Arjamaa O, Nikinmaa M, Salminen A et al (2009) Regulatory role of HIF-1 a in the pathogenesis of age-related macular. Ageing Res Rev 8:349–358
Atmani K, Voigt M, Le Tien V et al (2010) Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration. Eye (Lond) 24:1193–1198
Bottoni F, Massacesi A, Cigada M et al (2005) Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 123:1644–1650
Bressler NM, Bressler SB, Fine SL (1988) Age-related macular degeneration. Surv Ophthalmol 32:375–413
Campochiaro PA (2013) Ocular neovascularization. J Mol Med (Berl) 91:311–321
Caprara C, Grimm C (2012) From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease. Prog Retin Eye Res 31:89–119
Cash TP, Pan Y, Simon MC (2007) Reactive oxygen species and cellular oxygen sensing. Free Radic Biol Med 43:1219–1225
Cohen SY, Creuzot-Garcher C, Darmon J et al (2007) Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration. Br J Ophthalmol 91:1173–1176
Dehne N, Brune B (2009) HIF-1 in the inflammatory microenvironment. Exp Cell Res 315:1791–1797
Dorrell MI, Aguilar E, Jacobson R et al (2009) Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress. J Clin Invest 119:611–623
Engelbert M, Zweifel SA, Freund KB (2009) “Treat and extend” dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation. Retina 29:1424–1431
Freund KB, Ho IV, Barbazetto IA et al (2008) Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 28:201–211
Frykman PK, Brown MS, Yamamoto T et al (1995) Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc Natl Acad Sci U S A 92:8453–8457
Grimm C, Wenzel A, Groszer M et al (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8:718–724
Gross NE, Aizman A, Brucker A et al (2005) Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 25:713–718
Grossniklaus HE, Kang SJ, Berglin L (2010) Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res 29:500–519
Harris A, Chung HS, Ciulla TA et al (1999) Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog Retin Eye Res 18:669–687
Hartnett ME, Weiter JJ, Staurenghi G et al (1996) Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 103:2042–2053
Heckenlively JR, Hawes NL, Friedlander M et al (2003) Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 23:518–522
Hu W, Jiang A, Liang J et al (2008) Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation. Invest Ophthalmol Vis Sci 49:407–415
Inoue Y, Yanagi Y, Matsuura K et al (2007) Expression of hypoxia-inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration. Br J Ophthalmol 91:1720–1721
Jaakkola P, Mole DR, Tian YM et al (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468–472
Joyal JS, Sun Y, Gantner ML et al (2016) Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1. Nat Med 22:439–445
Kent DL (2014) Age-related macular degeneration: beyond anti-angiogenesis. Mol Vis 20:46–55
Kim JH, Kim JR, Kang SW et al (2013) Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration. Am J Ophthalmol 155:743–749. 749 e741–742
Kurihara T, Westenskow PD, Bravo S et al (2012) Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 122:4213–4217
Kurihara T, Westenskow PD, Gantner ML et al (2016) Hypoxia-induced metabolic stress in retinal pigment epithelial cells is sufficient to induce photoreceptor degeneration. elife 5:pii:e14319
Kvanta A, Algvere PV, Berglin L et al (1996) Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37:1929–1934
Lashkari K, Hirose T, Yazdany J et al (2000) Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol 156:1337–1344
Lopez PF, Sippy BD, Lambert HM et al (1996) Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 37:855–868
Massacesi AL, Sacchi L, Bergamini F et al (2008) The prevalence of retinal angiomatous proliferation in age-related macular degeneration with occult choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 246:89–92
Ohno-Matsui K, Hirose A, Yamamoto S et al (2002) Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol 160:711–719
Okamoto N, Tobe T, Hackett SF et al (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 151:281–291
Scott AW, Bressler SB (2010) Retinal angiomatous proliferation or retinal anastomosis to the lesion. Eye (Lond) 24:491–496
Shimada H, Kawamura A, Mori R et al (2007) Clinicopathological findings of retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245:295–300
Slakter JS, Yannuzzi LA, Schneider U et al (2000) Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 107:742–753. discussion 753–744
Solomon SD, Lindsley K, Vedula SS et al (2014) Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev: CD005139
Spaide RF (2013) Clinical manifestations of choroidal neovascularization in AMD. In: Holz FG, Pauleikhoff D, Spaide RF, Bird AC (eds) Age-related macular degeneration. Springer, Berlin, Heidelberg
Thiersch M, Lange C, Joly S et al (2009) Retinal neuroprotection by hypoxic preconditioning is independent of hypoxia-inducible factor-1 alpha expression in photoreceptors. Eur J Neurosci 29:2291–2302
Tiebel O, Oka K, Robinson K et al (1999) Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. Atherosclerosis 145:239–251
Tobe T, Okamoto N, Vinores MA et al (1998) Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 39:180–188
Vinores SA, Xiao WH, Aslam S et al (2006) Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J Cell Physiol 206:749–758
Yannuzzi LA, Negrao S, Iida T et al (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:416–434
Yannuzzi LA, Freund KB, Takahashi BS (2008) Review of retinal angiomatous proliferation or type 3 neovascularization. Retina 28:375–384
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this paper
Cite this paper
Barben, M., Samardzija, M., Grimm, C. (2018). The Role of Hypoxia, Hypoxia-Inducible Factor (HIF), and VEGF in Retinal Angiomatous Proliferation. In: Ash, J., Anderson, R., LaVail, M., Bowes Rickman, C., Hollyfield, J., Grimm, C. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 1074. Springer, Cham. https://doi.org/10.1007/978-3-319-75402-4_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-75402-4_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-75401-7
Online ISBN: 978-3-319-75402-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)